当前位置：易推广 > 上海陶术生物科技有限公司 > 产品展示
企业档案
会员类型：会员
已获得易推广信誉 等级评定
(0 -40)基础信誉积累，可浏览访问
(41-90)良好信誉积累，可接洽商谈
(91+ )优质信誉积累，可持续信赖
易推广会员：5年
工商认证 【已认证】
最后认证时间：
注册号： 【已认证】
法人代表： 【已认证】
企业类型：生产商 【已认证】
注册资金：人民币万 【已认证】
产品数：86101
参观次数：3755529
自主品牌
已选条件
-
T15709Lapaquistat acetateLapaquistat acetate,TAK-475,
Lapaquistat acetate is originally intended use to Mevalonate Kinase Deficiency (MKD), it is effective at lowering low-density lipoprotein cholesterol, but it might cause liver damage. Lapaquistat acetate is a squalene synthase inhibitor. It also blocks th
价 格：￥电议型 号：T15709产 地：美洲
-
T15710LapaquistatLapaquistat,T-91485,
Lapaquistat is a cholesterol biosynthesis inhibitor and is the active metabolite of TAK-475. Lapaquistat can reduce statin-induced myotoxicity in lipid-lowering therapy.
价 格：￥电议型 号：T15710产 地：美洲
-
T15710Lapaquistat；化合物 T15710T-91485；T-91485
Lapaquistat is a cholesterol biosynthesis inhibitor and is the active metabolite of TAK-475. Lapaquistat can reduce statin-induced myotoxicity in lipid-lowering therapy.
价 格：￥电议型 号：T15710产 地：中国大陆
-
T15709Lapaquistat acetate；化合物 T15709TAK-475；TAK-475
Lapaquistat acetate is a squalene synthase inhibitor. It also blocks the conversion of farnesyl diphosphate (FPP) to squalene. Lapaquistat acetate is used to Mevalonate Kinase Deficiency (MKD), it is effective at lowering low-density lipoprotein cholesterol, but it might cause liver damage.
价 格：￥电议型 号：T15709产 地：中国大陆
